Rochester Ophthalmological Group — Rochester, New York

Rochester Ophthalmological Group is a clinical research site located in Rochester, New York, United States 14618.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Rochester Ophthalmological Group has participated in 11 clinical trials with 1 currently active.

Therapeutic areas: Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca.

Sponsors: Mimetogen Pharmaceuticals USA, Inc., RVL Pharmaceuticals, Inc., Ocuphire Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester Ophthalmological Group?

Rochester Ophthalmological Group has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester Ophthalmological Group conducted?

Rochester Ophthalmological Group has 11 clinical trials on record, with 1 currently active. Their work covers Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca.

Is Rochester Ophthalmological Group accredited by Crixeo Health?

Yes — Rochester Ophthalmological Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rochester Ophthalmological Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.